SOLICITATION NOTICE
A -- SBIR/STTR Opportunity: First-in-Human Therapeutic Interfering Particle (TIP) Targeting a Respiratory Virus
- Notice Date
- 5/14/2019
- Notice Type
- Synopsis
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- 675 North Randolph Street <br> Arlington, VA 22203
- ZIP Code
- 22203
- Solicitation Number
- HR001119S0035-02
- Response Due
- 7/3/2019
- Archive Date
- 8/2/2019
- Point of Contact
- BAA Coordinator
- Small Business Set-Aside
- N/A
- Description
- The Defense Advanced Research Projects Agency (DARPA) Small Business Programs Office (SBPO) is issuing an SBIR/STTR Opportunity (SBO) inviting submissions of innovative research concepts in the technical domain(s) of therapeutic interfering particles as a medical countermeasure for use against viruses in humans. In particular, DARPA is interested in understanding the feasibility of Phase I Clinical Trials for Therapeutic Interfering Particles. This SBO is issued under the Broad Agency Announcement (BAA) for SBIR/STTR, HR001119S0035. All proposals in response to the technical area(s) described herein will be submitted in accordance with the instructions provided under HR001119S0035, published at: https://www.fbo.gov/spg/ODA/DARPA/CMO/HR001119S0035/listing.html. This SBO will open for proposals on June 5, 2019 and close on July 3, 2019. NOTE: THIS NOTICE WAS NOT POSTED TO FEDBIZOPPS ON THE DATE INDICATED IN THE NOTICE ITSELF (14-MAY-2019); HOWEVER, IT DID APPEAR IN THE FEDBIZOPPS FTP FEED ON THIS DATE. PLEASE CONTACT 877-472-3779 or fbo.support@gsa.gov REGARDING THIS ISSUE.
- Web Link
-
Link To Document
(https://www.fbo.gov/spg/ODA/DARPA/CMO/HR001119S0035-02/listing.html)
- Record
- SN05310351-F 20190516/190514230008 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |